Skip to content

Virtual Reality vs Inperson Simulation: A Non-inferiority Study

Virtual Reality vs Inperson Simulation: A Non-inferiority Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03863314
Enrollment
120
Registered
2019-03-05
Start date
2019-07-09
Completion date
2019-11-15
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Work-Related Condition

Keywords

Virtual Reality, Simulation, Workplace

Brief summary

The purpose of this study is to determine if Virtual Reality (VR) can elicit emotional responses that are captured via physiological biometrics such as heart rate variability and skin conductance levels. As a non-inferiority study the investigators anticipate the technologies will elicit an emotional not inferior to those responses of an in-person simulations of workplace scenarios (i.e medical error and workplace harassment).

Interventions

OTHERIn-person Simulation

In-person simulation of workplace-related scenarios with live actors

Virtual simulation of workplace-related scenarios of pre-recorded videos using the same actors

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Greater than 18 years of age * Personnel working or volunteering at Lucile Packard Children's Hospital (LPCH) or Stanford Health Care (SHC) facilities

Exclusion criteria

* Patients who do not consent * Are currently taking beta blockers or other chronotropic heart medication(s) * Have a history of severe motion sickness * Currently have nausea * Currently experiencing seizures * Are clinically unstable

Design outcomes

Primary

MeasureTime frameDescription
Respiratory sinus arrhythmiaThroughout duration of simulation, approximately 15 minutesBiometric sensors will be placed in strategic locations in order to collect respiratory sinus arrhythmia throughout either in-person or virtual simulation

Secondary

MeasureTime frameDescription
Skin conductance levelsThroughout duration of simulation, approximately 15 minutesSkin conductance levels as measured by electrodermal activity will be collected using biometric sensors throughout either in-person or virtual simulation
Emotional levelsThroughout duration of intervention, two minutes before and after the interventionEmotional affect will be self reported via validated scale before and after the intervention.
VR Simulation QuestionnaireThree months post study, approximately 5 minutesParticipants will be given a questionnaire regarding their virtual or in-person simulation experience and the overall similarity to real-life on a scale from 1-5 (1=Completely Different and 5=Nearly Identical) Example Questions: How true to real life were the emotions expressed during the scenario? and How true to real life was the the clinical environment?

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026